Ubiquitin-Proteasome System Regulation of an Evolutionarily Conserved RNA Polymerase II-Associated Factor 1 Involved in Pancreatic Oncogenesis.

The evolutionarily conserved RNA polymerase II-associated factor 1 (Paf1) from yeast to humans regulates transcription and associated processes, and thus, malfunctions and/or misregulations of Paf1 are associated with cellular pathologies. Indeed, Paf1 (also known as PD2 or pancreatic differentiation 2) is found to be upregulated in poorly differentiated cancer cells, and such upregulation is involved in cellular transformation or oncogenesis. However, the basis for Paf1 upregulation in these cells remains largely unknown. In light of this, we have tested here the idea that the ubiquitin-proteasome system (UPS) regulates the cellular abundance of Paf1. In this direction, we analyzed the role of UPS in regulation of Paf1's abundance in yeast. We find that Paf1 undergoes ubiquitylation and is degraded by the 26S proteasome in yeast, thus deciphering UPS regulation of an evolutionarily conserved factor, Paf1, involved in various cellular processes at the crossroads of the cancer networks. Likewise, Paf1 undergoes proteasomal degradation in well-differentiated, but not poorly differentiated, pancreatic cancer cells, hence pointing to the UPS in upregulation of Paf1 in poorly differentiated cancers. Collectively, our results reveal UPS regulation of Paf1 and suggest downregulation of UPS in elevating Paf1's abundance in poorly differentiated cancers.

[1]  S. Batra,et al.  hPaf1/PD2 interacts with OCT3/4 to promote self-renewal of ovarian cancer stem cells , 2017, Oncotarget.

[2]  S. Bhaumik,et al.  Fine-Tuning of FACT by the Ubiquitin Proteasome System in Regulation of Transcriptional Elongation , 2016, Molecular and Cellular Biology.

[3]  Lynette M. Smith,et al.  Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma , 2015, Oncotarget.

[4]  M. Wislez,et al.  Human RNA polymerase II associated factor 1 complex promotes tumorigenesis by activating c-MYC transcription in non-small cell lung cancer. , 2015, Biochemical and biophysical research communications.

[5]  S. Seal,et al.  Germline mutations in the PAF1 complex gene CTR9 predispose to Wilms tumour , 2014, Nature Communications.

[6]  S. Batra,et al.  Novel role of pancreatic differentiation 2 in facilitating self-renewal and drug resistance of pancreatic cancer stem cells , 2014, British Journal of Cancer.

[7]  S. Batra,et al.  PD2/Paf1 depletion in pancreatic acinar cells promotes acinar-to-ductal metaplasia , 2014, Oncotarget.

[8]  Geetha Durairaj,et al.  A new regulatory pathway of mRNA export by an F-box protein, Mdm30 , 2012, RNA.

[9]  S. Bhaumik,et al.  The 19S proteasome subcomplex promotes the targeting of NuA4 HAT to the promoters of ribosomal protein genes to facilitate the recruitment of TFIID for transcriptional initiation in vivo , 2011, Nucleic acids research.

[10]  S. Batra,et al.  Human RNA Polymerase II-Association Factor 1 (hPaf1/PD2) Regulates Histone Methylation and Chromatin Remodeling in Pancreatic Cancer , 2011, PloS one.

[11]  S. Bhaumik.  Distinct regulatory mechanisms of eukaryotic transcriptional activation by SAGA and TFIID. , 2011, Biochimica et biophysica acta.

[12]  R. Roeder,et al.  The Human PAF1 Complex Acts in Chromatin Transcription Elongation Both Independently and Cooperatively with SII/TFIIS , 2010, Cell.

[13]  S. Batra,et al.  RNA Polymerase II Associated Factor 1/PD2 Maintains Self‐Renewal by Its Interaction with Oct3/4 in Mouse Embryonic Stem Cells , 2009, Stem cells.

[14]  A. Shukla,et al.  The 19 S Proteasome Subcomplex Establishes a Specific Protein Interaction Network at the Promoter for Stimulated Transcriptional Initiation in Vivo* , 2009, The Journal of Biological Chemistry.

[15]  S. Batra,et al.  The Human RNA Polymerase II-Associated Factor 1 (hPaf1): A New Regulator of Cell-Cycle Progression , 2009, PloS one.

[16]  S. Gygi,et al.  Hexameric assembly of the proteasomal ATPases is templated through their C-termini , 2009, Nature.

[17]  A. Beyer,et al.  The Paf1 complex is required for efficient transcription elongation by RNA polymerase I , 2009, Proceedings of the National Academy of Sciences.

[18]  S. Bhaumik,et al.  Diverse Regulatory Mechanisms of Eukaryotic Transcriptional Activation by the Proteasome Complex , 2008, Critical reviews in biochemistry and molecular biology.

[19]  S. Batra,et al.  Human RNA polymerase II-associated factor complex: dysregulation in cancer , 2007, Oncogene.

[20]  J. Sikela,et al.  The human homologue of the RNA polymerase II-associated factor 1 (hPaf1), localized on the 19q13 amplicon, is associated with tumorigenesis , 2006, Oncogene.

[21]  R. Deshaies,et al.  A putative stimulatory role for activator turnover in gene expression , 2005, Nature.

[22]  Paul Tempst,et al.  The human PAF complex coordinates transcription with events downstream of RNA synthesis. , 2005, Genes & development.

[23]  K. Shokat,et al.  The F Box Protein Dsg1/Mdm30 Is a Transcriptional Coactivator that Stimulates Gal4 Turnover and Cotranscriptional mRNA Processing , 2005, Cell.

[24]  J. Jaehning,et al.  The Paf1 complex has functions independent of actively transcribing RNA polymerase II. , 2004, Molecular cell.

[25]  S. Johnston,et al.  Evidence That Proteolysis of Gal4 Cannot Explain the Transcriptional Effects of Proteasome ATPase Mutations* , 2001, The Journal of Biological Chemistry.

[26]  C. Chang,et al.  Cdc73p and Paf1p are found in a novel RNA polymerase II-containing complex distinct from the Srbp-containing holoenzyme , 1997, Molecular and cellular biology.

[27]  Brett N. Tomson,et al.  The many roles of the conserved eukaryotic Paf1 complex in regulating transcription, histone modifications, and disease states. , 2013, Biochimica et biophysica acta.